Investment
Features
FeesSafety
Academy
More
Pluang+

Compare UnitedHealth Group Inc (UNH) vs US Bancorp (USB) Price & Performance

UnitedHealth Group IncTrade
US BancorpTrade

Price performance (Past 24H)

Key statistics

UnitedHealth Group Inc vs US Bancorp — how do they compare? UnitedHealth Group Inc trades at $379.3 (market cap $332.96B), while US Bancorp trades at $57.08 (market cap $88.86B). The key difference: UnitedHealth Group Inc is far larger — about 3.7× US Bancorp's market cap, and US Bancorp pays the higher dividend (3.79%). Which is the better fit depends on your goals — on Pluang, investors hold UnitedHealth Group Inc for 97 Days and US Bancorp for 97 Days on average.

UNHUSB
Market Cap
$332.96B$88.86B
Volume
7,273,7498,869,993
Sector
HealthFinancials
52-Week High
$436.35$65.42
52-Week Low
$259.02$45.28
Typical Hold Time
97 Days97 Days
Enterprise Value
$374.82B$118.35B
Dividend Yield
2.5%3.79%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

UnitedHealth Group Inc

UnitedHealth Group (UNH) trades at $370.95, down 1.34% on the day, amid a bearish technical signal from moving averages. The company reported strong Q2 2026 earnings, beating estimates with EPS of $6.38 versus $4.91 expected, and raised full-year guidance. Revenue for 2025 reached $447.57 billion, though net income margin declined to 2.69%. Analyst consensus remains strongly bullish with an 82.69% buy rating and a $470.11 price target, suggesting significant upside from current levels.

UNH presents a compelling investment case driven by earnings beats, raised 2026 outlook, and strategic initiatives like AI investment in Optum. Key risks include regulatory pressures in healthcare, volatility from Medicare Advantage plan changes, and margin compression. The stock's valuation at a P/E of 23.84 appears reasonable given growth prospects, but investors should weigh execution risks against the positive analyst sentiment and institutional backing.

US Bancorp

U.S. Bancorp (USB) trades at $57.03, up 1.53% today, with a bearish technical signal but strong fundamentals including 11.38 P/E ratio and 27.61% net margin. The company has beaten earnings estimates for three consecutive quarters, with Q3 2026 results pending. Recent news highlights dividend increases and strong fee revenue momentum, while technical indicators show the stock testing key support levels near $55-56.

USB presents a value opportunity with attractive valuation metrics and consistent earnings beats, though near-term technical weakness and regulatory uncertainties pose risks. The 51% analyst buy rating and $69.94 consensus target suggest 23% upside potential, supported by dividend growth and solid banking operations in a rising rate environment.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

UNH
71% Buy29% Sell
Avg holding period · 97 Days
USB

No sentiment data available yet.

Top news

Latest headlines on both assets

About UnitedHealth Group Inc

UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.

Read more on UNH →

About US Bancorp

As a diversified financial-services provider, U.S. Bancorp is one of the nation's largest regional banks, with branches in well over 20 states, primarily in the Western and Midwestern United States. The bank offers many services, including retail banking, commercial banking, trust and wealth services, credit cards, mortgages, and other payments capabilities.

Read more on USB →